---
figid: PMC9408832__ijms-23-09255-g003
figtitle: Targeting the Sphingolipid Rheostat in Gliomas
organisms:
- Saccharomyces cerevisiae
- Candida dubliniensis
- Bikinia letestui
- Cannabis sativa
- Saccharomyces cerevisiae SK1
- Saccharomyces cerevisiae VL3
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Homo sapiens
- Bos taurus
pmcid: PMC9408832
filename: ijms-23-09255-g003.jpg
figlink: /pmc/articles/PMC9408832/figure/ijms-23-09255-f003/
number: F3
caption: Sphingolipid pathway and the fates of ceramide. Drugs that have been involved
  in clinical trials on glioma patients (listed in ) are in blue boxes. Pre-clinical
  drugs are listed in red or green boxes, depending on their status as inhibitors
  or activators. Additional research translating preclinical drugs may result in novel
  clinical trials on glioma patients and other cancer types. SPT, serine palmitoyl-CoA
  transferase; KDSR, keto-dihydrosphingosine reductase; CerS, ceramide synthase; DEGS,
  dihydroceramide desaturase; SGMS, sphingomyelin synthase; SMPD, sphingomyelinase;
  CERK, ceramide kinase; C1PP, ceramide 1-phosphate phosphatase; UGCG, UDP-glucose
  ceramide glucosyltransferase; GBA, glucocerebrosidase; ASAH/ACER, ceramidase; SPHK,
  sphingosine kinase; SGPP, sphingosine phosphate phosphatase; SGPL, sphingosine phosphate
  lyase.
papertitle: Targeting the Sphingolipid Rheostat in Gliomas.
reftext: Faris Zaibaq, et al. Int J Mol Sci. 2022 Aug;23(16):9255.
year: '2022'
doi: 10.3390/ijms23169255
journal_title: International Journal of Molecular Sciences
journal_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords: sphingolipids | ceramide | sphingosine-1-phosphate | rheostat | brain tumors
  | isocitrate dehydrogenase 1 mutation | gliomas
automl_pathway: 0.9407945
figid_alias: PMC9408832__F3
figtype: Figure
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Bos taurus
- Cricetulus griseus
redirect_from: /figures/PMC9408832__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9408832__ijms-23-09255-g003.html
  '@type': Dataset
  description: Sphingolipid pathway and the fates of ceramide. Drugs that have been
    involved in clinical trials on glioma patients (listed in ) are in blue boxes.
    Pre-clinical drugs are listed in red or green boxes, depending on their status
    as inhibitors or activators. Additional research translating preclinical drugs
    may result in novel clinical trials on glioma patients and other cancer types.
    SPT, serine palmitoyl-CoA transferase; KDSR, keto-dihydrosphingosine reductase;
    CerS, ceramide synthase; DEGS, dihydroceramide desaturase; SGMS, sphingomyelin
    synthase; SMPD, sphingomyelinase; CERK, ceramide kinase; C1PP, ceramide 1-phosphate
    phosphatase; UGCG, UDP-glucose ceramide glucosyltransferase; GBA, glucocerebrosidase;
    ASAH/ACER, ceramidase; SPHK, sphingosine kinase; SGPP, sphingosine phosphate phosphatase;
    SGPL, sphingosine phosphate lyase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Ugcg
  - Cerk
  - Gba1
  - Gba2
  - Spt
  - Agxt
  - Sgms1
  - Sgms2
  - Smpd1
  - Smpd3
  - Smpd2
  - Smpd4
  - Smpd5
  - Kdsr
  - Cers5
  - Cers6
  - Cers2
  - Cers4
  - Cers3
  - Cers1
  - Sgpp1
  - Sgpp2
  - Degs2
  - Degs1
  - Asah1
  - Asah2
  - Acer1
  - Acer3
  - Acer2
  - Sphk1
  - Sgpl1
  - Sptssa
  - Skic2
  - UGCG
  - CERK
  - GBA1
  - GBA1LP
  - GBA2
  - AGXT
  - SGMS1
  - SGMS2
  - SMPD1
  - SMPD3
  - SMPD2
  - SMPD4
  - SMPD5
  - KDSR
  - CERS5
  - CERS6
  - CERS2
  - CERS4
  - CERS3
  - CERS1
  - GDF1
  - SGPP1
  - SGPP2
  - DEGS2
  - DEGS1
  - ASAH1
  - ASAH2
  - ACER1
  - ACER3
  - ACER2
  - SPHK1
  - SPHK2
  - SGPL1
  - SPTSSA
  - WAS
  - SKIC2
  - S1PR1
  - S1PR2
  - S1PR3
  - S1PR4
  - S1PR5
---
